Prestige Consumer Healthcare (PBH) Other Non-Current Assets (2011 - 2025)

Prestige Consumer Healthcare (PBH) recorded quarterly Other Non-Current Assets of $3.8 million in Q4 2025, up 10.2% quarter-over-quarter from $3.4 million in Q3 2025, and down 40.16% on a YoY basis from $6.3 million in Q4 2024.

Prestige Consumer Healthcare (PBH) Other Non-Current Assets (2011 - 2025) Analysis & Trends

Prestige Consumer Healthcare's Other Non-Current Assets history runs 15 years deep, the most recent figure standing at $3.8 million for Q4 2025.

  • In Q4 2025, Other Non-Current Assets fell 40.16% year-over-year to $3.8 million; the TTM figure through Dec 2025 stood at $3.8 million (down 40.16% YoY), while the FY2025 annual figure was $3.3 million, down 42.83% from the prior year.
  • Other Non-Current Assets was $3.8 million for Q4 2025 at Prestige Consumer Healthcare, up from $3.4 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $6.7 million in Q3 2024 to a low of $2.5 million in Q2 2021.
  • Historically, Other Non-Current Assets has averaged $3.9 million across 5 years, with a median of $3.3 million in 2022.
  • The sharpest annual moves came in 2023 and 2025: Other Non-Current Assets surged 99.84% in 2023, then plunged 51.48% in 2025.
  • A 5-year view of Other Non-Current Assets shows it stood at $2.9 million in 2021, then increased by 9.13% to $3.2 million in 2022, then soared by 99.84% to $6.3 million in 2023, then grew by 0.57% to $6.3 million in 2024, then slumped by 40.16% to $3.8 million in 2025.
  • The last three Other Non-Current Assets figures came in at $3.8 million (Q4 2025), $3.4 million (Q3 2025), and $3.0 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 1.79 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 351.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 233.20 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 3.45 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 73.60 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 295.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 59.36 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 47.63 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -
10 Prestige Consumer Healthcare 2.37 Bn 2.31 Bn 157.37 Mn 3.79 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 3.79 Mn
Sep 30, 2025 3.44 Mn
Jun 30, 2025 3.02 Mn
Mar 31, 2025 3.27 Mn
Dec 31, 2024 6.34 Mn
Sep 30, 2024 6.73 Mn
Jun 30, 2024 6.23 Mn
Mar 31, 2024 5.73 Mn
Dec 31, 2023 6.30 Mn
Sep 30, 2023 3.86 Mn
Jun 30, 2023 3.27 Mn
Mar 31, 2023 3.01 Mn
Dec 31, 2022 3.15 Mn
Sep 30, 2022 2.58 Mn
Jun 30, 2022 2.74 Mn
Mar 31, 2022 3.27 Mn
Dec 31, 2021 2.89 Mn
Sep 30, 2021 2.56 Mn
Jun 30, 2021 2.52 Mn
Mar 31, 2021 2.86 Mn